Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (28)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Weiss, K.
Right arrow Articles by Low, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiss, K.
Right arrow Articles by Low, D. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 47, 345-348
© 2001 The British Society for Antimicrobial Chemotherapy


Brief report

Phenotypic and genotypic characterization of macrolide-resistant group A Streptococcus strains in the province of Quebec, Canada

K. Weissa,c,*, J. De Azavedob, C. Restieria,c, L. A. Galarneauc, M. Gourdeauc, P. Harveyc, J. F. Paradisc, K. Salimb and D. E. Lowb

a Hôpital Maisonneuve-Rosemont, University of Montreal, Montreal, Quebec; b Mount Sinai Hospital, University of Toronto, Toronto, Ontario; c Groupe de Recherche sur les Anti-Microbiens (GRAM), Hôpital Maisonneuve-Rosemont, 5415 L'Assomption, Montreal, Quebec, Canada H1T 2M4

Resistance to macrolides among group A streptococci is an increasing problem worldwide. We examined 496 strains phenotypically and genotypically for resistance to erythromycin and clindamycin. Strains were isolated in five different geographical areas representing about 45% of the total Quebec population. The overall resistance rate was 4.6% but varied from 0% in rural areas to 9.4% in Montreal. Of the 23 strains showing resistance to erythromycin, 15 (65%) had an identical pulsed-field gel electrophoresis pattern, were of serotype M28T28 and harboured the erm(TR) gene, suggesting the spread of a single clone. Of the remaining eight strains, two strains had the erm(B) gene, five had the mef gene and one with a different serotype also had the erm(TR) gene.

* Corresponding author. Hôpital Maisonneuve-Rosemont, 5415 L'Assomption, Montreal, Quebec, Canada H1T 2M4. Tel: +1-514-252-3817; Fax: +1-514-252-3898; E-mail: weisscan{at}aol.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
P. Littauer, D. A. Caugant, M. Sangvik, E. A. Hoiby, A. Sundsfjord, G. S. Simonsen, and the Norwegian Macrolide Study Group
Macrolide-Resistant Streptococcus pyogenes in Norway: Population Structure and Resistance Determinants.
Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1896 - 1899.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. Green, C. Allen, J. Bradley, B. Dashefsky, J. R. Gilsdorf, M. J. Marcon, G. E. Schutze, C. Smith, E. Walter, J. M. Martin, et al.
In Vitro Activity of Telithromycin against Macrolide-Susceptible and Macrolide-Resistant Pharyngeal Isolates of Group A Streptococci in the United States
Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2487 - 2489.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
G. Erdem, J. Ford, D. Johnson, L. Abe, K. Yamaga, and E. Kaplan
Erythromycin-Resistant Group A Streptococcal Isolates Collected between 2000 and 2005 in Oahu, Hawaii, and Their emm Types
J. Clin. Microbiol., May 1, 2005; 43(5): 2497 - 2499.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
C. H. W. Klaassen and J. W. Mouton
Molecular Detection of the Macrolide Efflux Gene: To Discriminate or Not To Discriminate between mef(A) and mef(E)
Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1271 - 1278.
[Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
G. J. Tyrrell, M. Lovgren, B. Kress, and K. Grimsrud
Invasive Group A Streptococcal Disease in Alberta, Canada (2000 to 2002)
J. Clin. Microbiol., April 1, 2005; 43(4): 1678 - 1683.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. Desjardins, K. L. Delgaty, K. Ramotar, C. Seetaram, and B. Toye
Prevalence and Mechanisms of Erythromycin Resistance in Group A and Group B Streptococcus: Implications for Reporting Susceptibility Results
J. Clin. Microbiol., December 1, 2004; 42(12): 5620 - 5623.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
E. Bingen, P. Bidet, L. Mihaila-Amrouche, C. Doit, S. Forcet, N. Brahimi, A. Bouvet, and R. Cohen
Emergence of Macrolide-Resistant Streptococcus pyogenes Strains in French Children
Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3559 - 3562.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. E. Hasenbein, J. E. Warner, K. G. Lambert, S. E. Cole, A. B. Onderdonk, and A. J. McAdam
Detection of Multiple Macrolide- and Lincosamide-Resistant Strains of Streptococcus pyogenes from Patients in the Boston Area
J. Clin. Microbiol., April 1, 2004; 42(4): 1559 - 1563.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
A. Portillo, M. J. Gastanares, F. Ruiz-Larrea, and C. Torres
Clonal diversity among erythromycin-resistant {beta}-haemolytic Streptococcus isolates in La Rioja, Spain
J. Antimicrob. Chemother., September 1, 2003; 52(3): 485 - 488.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
P.-R. Hsueh, L.-J. Teng, C.-M. Lee, W.-K. Huang, T.-L. Wu, J.-H. Wan, D. Yang, J.-M. Shyr, Y.-C. Chuang, J.-J. Yan, et al.
Telithromycin and Quinupristin-Dalfopristin Resistance in Clinical Isolates of Streptococcus pyogenes: SMART Program 2001 Data
Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2152 - 2157.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
K. C. Katz, A. J. McGeer, C. L. Duncan, A. Ashi-Sulaiman, B. M. Willey, A. Sarabia, J. McCann, S. Pong-Porter, Y. Rzayev, J. S. de Azavedo, et al.
Emergence of Macrolide Resistance in Throat Culture Isolates of Group A Streptococci in Ontario, Canada, in 2001
Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2370 - 2372.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
P. L. Ho, D. R. Johnson, A. W. Y. Yue, D. N. C. Tsang, T. L. Que, B. Beall, and E. L. Kaplan
Epidemiologic Analysis of Invasive and Noninvasive Group A Streptococcal Isolates in Hong Kong
J. Clin. Microbiol., March 1, 2003; 41(3): 937 - 942.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
G. Dicuonzo, E. Fiscarelli, G. Gherardi, G. Lorino, F. Battistoni, S. Landi, M. De Cesaris, T. Petitti, and B. Beall
Erythromycin-Resistant Pharyngeal Isolates of Streptococcus pyogenes Recovered in Italy
Antimicrob. Agents Chemother., December 1, 2002; 46(12): 3987 - 3990.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
A. Detcheva, R. R. Facklam, and B. Beall
Erythromycin-Resistant Group A Streptococcal Isolates Recovered in Sofia, Bulgaria, from 1995 to 2001
J. Clin. Microbiol., October 1, 2002; 40(10): 3831 - 3834.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
C. Garcia-Rey, L. Aguilar, F. Baquero, J. Casal, and J. E. Martin
Pharmacoepidemiological Analysis of Provincial Differences between Consumption of Macrolides and Rates of Erythromycin Resistance among Streptococcus pyogenes Isolates in Spain
J. Clin. Microbiol., August 1, 2002; 40(8): 2959 - 2963.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.